This is the same company that settled off-label marketing claims in October for $14.5 million (following a $2.3 billion settlement of related suits). And it's the same company that agreed last month to pay $60 million to settle allegations of paying bribes to overseas officials.
Tuesday, December 13, 2011
Government penalties don't slow Pfizer
The Wall St. Journal reports that Pfizer raised its divided by 10% and expanded its share repurchase plans by up to $10 billion, in an effort "to return some of its cash pile to shareholders."